
Organization · Venture Capital
Integra Holdings Ltd.
Integra Holdings Ltd. is a Jerusalem-based healthcare investment company that focuses on early-stage life sciences innovations, particularly those emerging from the Hebrew University of Jerusalem. The firm provides strategic support to its portfolio companies from inception to commercialization.
Overview
What Integra Holdings Ltd. does
What Integra Holdings Ltd. is
Integra Holdings Ltd. is a Jerusalem-based healthcare investment company that focuses on early-stage life sciences innovations, particularly those emerging from the Hebrew University of Jerusalem. The firm provides strategic support to its portfolio companies from inception to commercialization.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2012
- Approximate age
- About 14 years
- Structured capabilities
- Funder
- Last reviewed
- May 5, 2026
Official channels
Find Integra Holdings Ltd. elsewhere
Open the official website or a supported primary organization account.
Capability profile
Integra Holdings Ltd. as a funder
Investment thesis
Integra Holdings aims to translate Hebrew University life-science excellence into commercial healthcare companies, focusing on innovations and intellectual property emerging from the university.
Focus narrative
Integra Holdings invests in early-stage research and technologies in the life sciences, employing a multidisciplinary team to identify promising innovations. The company provides support from inception to commercialization, ensuring that groundbreaking research translates into viable healthcare solutions.
Value beyond capital
Integra Holdings adds value to its portfolio companies by providing hands-on commercialization support from inception through company maturity, leveraging its exclusive access to Hebrew University innovations and a multidisciplinary team to ensure scientific merit and commercial feasibility.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series B · Series C · Series D · Growth Equity
- Sectors
- Biotech · Healthcare · AI · Diagnostics · Medical Devices
- Regions
- Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 11
Portfolio context
Ayana Pharma: A late-stage company developing a lipid-based cytotoxic agent for cancer treatment, currently under FDA review. Nectin Therapeutics: Focused on developing next-generation immune oncology therapies for cancer patients. Splisense: A preclinical company developing antisense oligonucleotides for cystic fibrosis and other genetic diseases. HighRAD: Provides an intelligent computer assessment support system for analyzing multi-organ imaging data. Neoprol: A preclinical company developing a unique formulation of Propofol to address bacterial contamination issues. Lipocure: Developing novel liposomal formulations for post-surgical pain management. OPhRx: Focused on developing topical formulations for ocular diseases. RNAble: Developing compounds that modulate RNA stability for treating specific cancers and genetic diseases. Lipomedix: A Phase Ib company developing a novel liposomal prodrug for cancer therapy.
Connected ecosystem
Continue from Integra Holdings Ltd.
These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.
Same organization type
Structured sector focus
Common questions
What to know about Integra Holdings Ltd.
Upseed classifies Integra Holdings Ltd. under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.